Table 1 ACE genotype and allele distributions among controls and migraine patients in different studies
From: Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients
Genotypes | Alleles | |||||
|---|---|---|---|---|---|---|
N | DD(%) | ID(%) | II(%) | D(%) | I(%) | |
Controls | ||||||
Tronvik | 403 | 92 (26.6) | 204 (50.6) | 107 (22.8) | 388 (48.1) | 418 (51.9) |
Paterna (ref 8) | 201 | 75 (37.3) | 101 (50.3) | 25 (12.4) | 251 (62.4) | 151 (37.6) |
Lea (ref 9) | 244 | 76 (31.1) | 122 (50.0) | 46 (18.9) | 274 (56.1) | 214 (43.9) |
Kowa (ref 10) | 248 | 31 (12.5) | 114 (46.0) | 103 (41.5) | 176 (35.5) | 320 (64.5) |
Migraine | ||||||
Tronvik | 347 | 78 (22.5) | 186 (53.6) | 83 (23.9) | 342 (49.3) | 352 (50.7) |
Paterna | 302 | 146 (48.3) | 129 (42.7) | 27 (9.0) | 421 (69.7) | 183 (30.3) |
Lea | 250 | 77 (30.8) | 142 (56.8) | 31 (12.4) | 296 (59.2) | 204 (40.8) |
Kowa | 176 | 33 (18.7) | 86 (48.9) | 57 (32.4) | 152 (43.2) | 200 (56.8) |
MwA subgroup | ||||||
Tronvik | 155 | 34 (21.9) | 87 (56.1) | 34 (21.9) | 155 (50.0) | 155 (50.0) |
Paterna | NA | NA | NA | NA | NA | NA |
Lea | 151 | 48 (31.8) | 85 (56.3) | 18 (11.9) | 181 (59.9) | 121 (40.1) |
Kowa | 54 | 14 (25.9)* | 26 (48.2) | 14 (25.9) | 54 (50.0)* | 54 (50.0) |
MoA subgroup | ||||||
Tronvik | 187 | 43 (23.0) | 96 (51.3) | 48 (25.7) | 182 (48.7) | 192 (51.3) |
Paterna | 302 | 146 (48.3)* | 129 (42.7) | 27 (9.0) | 421 (69.7) | 183 (30.3) |
Lea | 99 | 29 (29.3) | 57 (57.6) | 13 (13.1) | 115 (58.1) | 83 (41.9) |
Kowa | 122 | 19 (15.6) | 60 (49.2) | 43 (35.2) | 98 (35.2) | 146 (59.8) |